DermaZinc

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DermaZinc
Generic name: PYRITHIONE ZINC
Manufacturer: WynnPharm Inc
Product type: HUMAN OTC DRUG
SPL set ID: e73010ae-291d-6adf-e053-2a95a90a8aea
SPL ID: 43881568-3560-4236-e063-6394a90ab554
Version: 4
Effective date: 2025-11-14
Source export date: 2026-10-12
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:58:05

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M032	openfda.application_number
brand name		DermaZinc	openfda.brand_name
generic name		PYRITHIONE ZINC	openfda.generic_name
manufacturer name		WynnPharm Inc	openfda.manufacturer_name
ndc	package	35324-002-04	openfda.package_ndc
ndc	product	35324-002	openfda.product_ndc
ndc11	package	35324000204	derived:openfda.package_ndc
rxcui		242537	openfda.rxcui
rxcui		1101635	openfda.rxcui
spl id		43881568-3560-4236-e063-6394a90ab554	id
spl set id		e73010ae-291d-6adf-e053-2a95a90a8aea	set_id
unii		R953O2RHZ5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings ■ For external use only. ■ Ask a doctor before use if you have a condition that covers a large area of the body. When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.